Harnessing the Placebo Effect in Pediatric Migraine Clinic - 23/09/14
Doi : 10.1016/j.jpeds.2014.06.040
Vanda Faria, PhD 1, 2, ⁎ 
, Clas Linnman, PhD 1, Alyssa Lebel, MD, PhD 1, 3, David Borsook, MD, PhD 1, 3
, Clas Linnman, PhD 1, Alyssa Lebel, MD, PhD 1, 3, David Borsook, MD, PhD 1, 3 1 Center for Pain and the Brain, Boston Children's Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA
2 Department of Psychology, Uppsala University, Uppsala, Sweden
3 Chronic Headache Program, Boston Children's Hospital, Harvard Medical School, Boston, MA
∗Reprint requests: Vanda Faria, PhD, Center for Pain and the Brain, c/o P.A.I.N. Group, Boston Children's Hospital and Massachusetts General Hospital, Harvard Medical School, 9 Hope Ave, Waltham, MA.
Keyword : IBS
Le texte complet de cet article est disponible en PDF.
Plan
| Supported by National Institute of Neurological Disorders and Stroke (K24NS064050 and R01NS0750182 to D.B.) and National Center for Complementary and Alternative Medicine (R21 AT007530-01 to D.B.). V.F. supported by the Ryochi Sasakawa Young Leaders Fellowship Fund. The authors declare no conflicts of interest. |
© 2014
Elsevier Inc. Tous droits réservés.
Vol 165 - N° 4
P. 659-665 - octobre 2014 Retour au numéro
Article précédent
- The Effect of Monitor Design and Implementation on Patient Management
- Juliann M. Di Fiore
- Impact of Study Oximeter Masking Algorithm on Titration of Oxygen Therapy in the Canadian Oxygen Trial
- Barbara Schmidt, Robin S. Roberts, Robin K. Whyte, Elizabeth V. Asztalos, Christian Poets, Yacov Rabi, Alfonso Solimano, Harvey Nelson, Canadian Oxygen Trial Group ?
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?